本コンテンツは、医療従事者にとって有用な学術情報をお届けすることを目的としており、
公平な立場から一定のキーワードを元に選択した高尿酸血症や痛風に関する記事をお届けしています。
一部、国内での承認外の情報が含まれることもありますが、これを推奨するものではありません。
また、特定の薬剤の処方誘引あるいは企業の営利を企図するものではありません。
治療、各薬剤の使用にあたっては最新の製品添付文書をご参照ください。
論文タイトルを押すとPubmedもしくは医中誌Webへ移動します。
※なお、医中誌Web利用には会員登録が必要になります。
2023.11.6
-
血液事業(0917-7833)46巻1号 Page65-68(2023.05)
2023/09/16
医中誌文献番号：X808080007
Jr(a-)型と痛風・高尿酸血症の共通の原因遺伝子ABCG2豊田 優(防衛医科大学校 医学教育部医学科分子生体制御学講座), 田中 光信, 中山 昌喜, 松尾 洋孝
-
日本老年医学会雑誌(0300-9173)60巻Suppl. Page147(2023.05)
2023/09/16
医中誌文献番号：2023278084
キサンチンオキシダーゼ阻害薬Febuxostatの白血球数への影響竹下 光英(佐賀大学 循環器内科), 田中 敦史, 野出 孝一
-
日本腎臓学会誌(0385-2385)65巻3号 Page329(2023.05)
2023/09/16
医中誌文献番号：2023308873
保存期CKD患者への新規尿酸降下薬ドチヌラドの使用経験(第2報)金森 弘志(福知山市民病院 腎臓内科)
-
日本腎臓学会誌(0385-2385)65巻3号 Page326(2023.05)
2023/09/16
医中誌文献番号：2023308856
高尿酸血症合併の保存期慢性腎臓病(CKD)症例に対するFebuxostatとDotinuradの併用効果 重症度分類による違い山田 剛久(日本医科大学千葉北総病院), 柏木 哲也, 酒井 行直
-
日本腎臓学会誌(0385-2385)65巻3号 Page289(2023.05)
2023/09/16
医中誌文献番号：2023308638
かかりつけ医による高尿酸血症を合併したCKD患者への尿酸降下薬使用実態の検討森野 諄紀(自治医科大学附属さいたま医療センター 腎臓内科), 矢内 克典, 平田 桃子, 植田 裕一郎, 大河原 晋, 森下 義幸
-
日本腎臓学会誌(0385-2385)65巻3号 Page202(2023.05)
2023/09/16
医中誌文献番号：2023308192
先天性代謝異常症と腎疾患 尿酸トランスポーター異常症貝藤 裕史(兵庫県立こども病院 腎臓内科)
-
J Inflamm Res. 2023 Sep 8;16:3937-3947. doi: 10.2147/JIR.S424820. eCollection 2023.
2023/09/14
The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
Pang L, Xue X, He Y, Wang C, Han L, Li M, Qi H, Li C, Lu J.
-
Redox Biol. 2023 Sep 4;67:102866. doi: 10.1016/j.redox.2023.102866. Online ahead of print.
2023/09/14
Hemin and iron increase synthesis and trigger export of xanthine oxidoreductase from hepatocytes to the circulation
DeVallance ER, Schmidt HM, Seman M, Lewis SE, Wood KC, Vickers SD, Hahn SA, Velayutham M, Hileman EA, Vitturi DA, Leonardi R, Straub AC, Kelley EE.
-
Mol Biotechnol. 2023 Sep 13. doi: 10.1007/s12033-023-00861-5. Online ahead of print.
2023/09/13
Effects of Zofenopril on Arterial Stiffness in Hypertension Patients
Palić B, Brizić I, Sher EK, Cvetković I, Džidić-Krivić A, Abdelghani HTM, Sher F.
-
J Biochem Mol Toxicol. 2023 Sep 13:e23529. doi: 10.1002/jbt.23529. Online ahead of print.
2023/09/13
N-acetyl-l-tryptophan (NAT) ameliorates radiation-induced cell death in murine macrophages J774A.1 via regulating redox homeostasis and mitochondrial dysfunction
Singh D, Malhotra P, Agarwal P, Kumar R.
-
Saudi Pharm J. 2023 Oct;31(10):101762. doi: 10.1016/j.jsps.2023.101762. Epub 2023 Aug 25.
2023/09/13
Multi-target action of Garcinia livingstonei extract and secondary metabolites against fatty acid synthase, α-glucosidase, and xanthine oxidase
Abdul-Rahman AM, Elwekeel A, Alruhaimi RS, Kamel EM, Bin-Ammar A, Mahmoud AM, Moawad AS, Zaki MA.
-
Cureus. 2023 Aug 12;15(8):e43361. doi: 10.7759/cureus.43361. eCollection 2023 Aug.
2023/09/13
Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia
Ubhadiya TJ, Dubey N, Sojitra MH, Shah K, Joshi S, Gandhi SK, Patel P.
-
Chem Biol Drug Des. 2023 Sep 12. doi: 10.1111/cbdd.14348. Online ahead of print.
2023/09/13
Design, synthesis, and evaluation of the in vitro activity of novel dual inhibitors of XOR and URAT1 containing a benzoic acid group
Zhu XY, Chen HM, Zhang L, Qin YX, Li J.
-
Nephrol Dial Transplant. 2023 Sep 12:gfad201. doi: 10.1093/ndt/gfad201. Online ahead of print.
2023/09/12
Serum uric acid levels and health outcomes in CKD: a prospective cohort study
Wu S, Xue W, Yu H, Yu H, Shi Z, Wang L, Peng A.
-
iScience. 2023 Aug 25;26(9):107730. doi: 10.1016/j.isci.2023.107730. eCollection 2023 Sep 15.
2023/09/11
URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease
Tanaka Y, Nagoshi T, Takahashi H, Oi Y, Yasutake R, Yoshii A, Kimura H, Kashiwagi Y, Tanaka TD, Shimoda M, Yoshimura M.
-
Int J Health Sci (Qassim). 2023 Sep-Oct;17(5):23-30.
2023/09/11
Therapeutic effect of bromelain and papain on intestinal injury induced by indomethacin in male rats
Madkhali JY, Hussein RH, Alnahdi HS.
-
Biochem Pharmacol. 2023 Oct;216:115794. doi: 10.1016/j.bcp.2023.115794. Epub 2023 Sep 7.
2023/09/10
Febuxostat alleviates Arsenic Trioxide-Induced renal injury in Rats: Insights on the crosstalk between NLRP3/TLR4, Sirt-1/NF-κB/TGF-β signaling Pathways, and miR-23b-3p, miR-181a-5b expression
Abdel-Wahab BA, El-Shoura EAM, Shafiuddin Habeeb M, Zafaar D.
-
Bioorg Chem. 2023 Nov;140:106818. doi: 10.1016/j.bioorg.2023.106818. Epub 2023 Aug 28.
2023/09/10
A New Avenue for Enhanced Treatment of Hyperuricemia and Oxidative Stress: Design, Synthesis and Biological Evaluation of Some Novel Mutual Prodrugs Involving Febuxostat Conjugated with Different Antioxidants
Rashad AY, Daabees HG, Elagawany M, Shahin M, Abdel Moneim AE, Rostom SAF.
-
Rheumatology (Oxford). 2023 Sep 9:kead468. doi: 10.1093/rheumatology/kead468. Online ahead of print.
2023/09/09
The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapy
Cao C, Gamble G, Horne A, Aati O, Doyle A, Drake J, Stamp LK, Dalbeth N.
-
Plants (Basel). 2023 Aug 25;12(17):3059. doi: 10.3390/plants12173059.
2023/09/09
Allantoin: A Potential Compound for the Mitigation of Adverse Effects of Abiotic Stresses in Plants
Kaur R, Chandra J, Varghese B, Keshavkant S.
-
Nutrients. 2023 Aug 23;15(17):3691. doi: 10.3390/nu15173691.
2023/09/09
Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial
Serrano JCE, Castro-Boqué E, García-Carrasco A, Morán-Valero MI, González-Hedström D, Bermúdez-López M, Valdivielso JM, Espinel AE, Portero-Otín M.
-
Int J Mol Sci. 2023 Aug 30;24(17):13434. doi: 10.3390/ijms241713434.
2023/09/09
Novel Insights into the Molecular Mechanisms of Atherosclerosis
Wojtasińska A, Frąk W, Lisińska W, Sapeda N, Młynarska E, Rysz J, Franczyk B.
-
Int J Mol Sci. 2023 Aug 29;24(17):13378. doi: 10.3390/ijms241713378.
2023/09/09
Antiplatelet Effects of Selected Xanthine-Based Adenosine A(2A) and A(2B) Receptor Antagonists Determined in Rat Blood
Kubacka M, Mogilski S, Bednarski M, Pociecha K, Świerczek A, Nicosia N, Schabikowski J, Załuski M, Chłoń-Rzepa G, Hockemeyer J, Müller CE, Kieć-Kononowicz K, Kotańska M.
-
Healthcare (Basel). 2023 Sep 3;11(17):2460. doi: 10.3390/healthcare11172460.
2023/09/09
Hyperuricemia as a Risk Factor in Hypertension among Patients with Very High Cardiovascular Risk
Muszyński P, Dąbrowski EJ, Pasławska M, Niwińska M, Kurasz A, Święczkowski M, Tokarewicz J, Kuźma Ł, Kożuch M, Dobrzycki S.
-
Nat Rev Rheumatol. 2023 Sep 8. doi: 10.1038/s41584-023-01006-3. Online ahead of print.
2023/09/09
Mechanisms and rationale for uricase use in patients with gout
Schlesinger N, Pérez-Ruiz F, Lioté F.
-
PLoS One. 2023 Sep 8;18(9):e0291330. doi: 10.1371/journal.pone.0291330. eCollection 2023.
2023/09/08
Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk
Feaver RE, Bowers MS, Cole BK, Hoang S, Lawson MJ, Taylor J, LaMoreaux BD, Zhao L, Henke BR, Johns BA, Nyborg AC, Wamhoff BR, Figler RA.
-
Medicine (Baltimore). 2023 Sep 8;102(36):e35087. doi: 10.1097/MD.0000000000035087.
2023/09/08
Analysis of the detection rate and related factors of fatty liver disease in physical examination of healthy population in Chengdu district
Han Q, Guo J, Gong L, Liu C, Zhang F.
-
Front Endocrinol (Lausanne). 2023 Aug 23;14:1195888. doi: 10.3389/fendo.2023.1195888. eCollection 2023.
2023/09/08
An elevated likelihood of stroke, ischemic heart disease, or heart failure in individuals with gout: a longitudinal follow-up study utilizing the National Health Information database in Korea
Kang HS, Lee NE, Yoo DM, Han KM, Hong JY, Choi HG, Lim H, Kim JH, Kim JH, Cho SJ, Nam ES, Park HY, Kim NY, Baek SU, Lee JY, Kwon MJ.
-
Int J Cardiol Heart Vasc. 2023 Aug 30;48:101264. doi: 10.1016/j.ijcha.2023.101264. eCollection 2023 Oct.
2023/09/08
Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry
Kurajoh M, Fukumoto S, Akari S, Murase T, Nakamura T, Ihara Y, Imai T, Nagata Y, Morioka T, Mori K, Imanishi Y, Watanabe T, Emoto M.
-
Med Int (Lond). 2023 Aug 7;3(4):40. doi: 10.3892/mi.2023.100. eCollection 2023 Jul-Aug.
2023/09/08
The nurse's role in managing gout in the modern era: A systematic review of the literature
Tsiamalou P, Brotis AG, Vrekou E, Georgakopoulou VE, Papalexis P, Aravanatinou-Fatorou A, Tegousi M, Fotakopoulos G, Paterakis K.
-
Arthritis Res Ther. 2023 Sep 7;25(1):164. doi: 10.1186/s13075-023-03152-1.
2023/09/08
Efficacy and safety of tart cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study
Wang C, Sun W, Dalbeth N, Wang Z, Wang X, Ji X, Xue X, Han L, Cui L, Li X, Liu Z, Ji A, He Y, Sun M, Li C.
-
Sci Rep. 2023 Sep 7;13(1):14720. doi: 10.1038/s41598-023-41764-4.
2023/09/08
Xanthine oxidase levels and immune dysregulation are independently associated with anemia in Plasmodium falciparum malaria
Vasquez M, Sica M, Namazzi R, Opoka RO, Sherman J, Datta D, Duran-Frigola M, Ssenkusu JM, John CC, Conroy AL, Rodriguez A.
-
Proteomics. 2023 Sep 7:e2300179. doi: 10.1002/pmic.202300179. Online ahead of print.
2023/09/08
Glutamine supplementation alleviated aortic atherosclerosis in mice model and in vitro
Zhang H, Wang C, Sun H, Zhou T, Ma C, Han X, Zhang T, Xia J.
-
Front Endocrinol (Lausanne). 2023 Aug 22;14:1197628. doi: 10.3389/fendo.2023.1197628. eCollection 2023.
2023/09/07
Association between serum uric acid levels and peripheral artery disease in Chinese adults with hypertension
Han F, Yu C, Hu F, Zhou W, Wang T, Zhu L, Huang X, Bao H, Cheng X.
-
Perfusion. 2023 Sep 6:2676591231202105. doi: 10.1177/02676591231202105. Online ahead of print.
2023/09/07
Comparison of the effect of uric acid/albumin ratio on coronary colleteral circulation with other inflammation-based markers in stable coronary artery disease patients
Toprak K, Yılmaz R, Kaplangoray M, Memioğlu T, İnanır M, Akyol S, Özen K, Biçer A, Demirbağ R.
-
Crit Rev Food Sci Nutr. 2023 Sep 6:1-14. doi: 10.1080/10408398.2023.2253468. Online ahead of print.
2023/09/06
The intestinal-hepatic axis: a comprehensive review on fructose metabolism and its association with mortality and chronic metabolic diseases
Dong Y, Li W, Yin J.
-
Turk Kardiyol Dern Ars. 2023 Sep;51(6):387-393. doi: 10.5543/tkda.2023.53389.
2023/09/06
Thyroid Functions Are Associated with All-Cause Long-Term Mortality in Elderly Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Emre E, Hancı K, Gökçek MD, Aktaş M, Kalaycıoğlu E, Çetin M, Karaüzüm K, Karaüzüm İ, Ural E.
-
J Korean Med Sci. 2023 Sep 4;38(35):e266. doi: 10.3346/jkms.2023.38.e266.
2023/09/05
Reliability and Validity of the Korean Version of the Gout Impact Scale
Kim MJ, Kim JY, Lee JJ, Moon KW, Shin K.
-
Cardiovasc Diabetol. 2023 Sep 4;22(1):240. doi: 10.1186/s12933-023-01972-8.
2023/09/05
BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity
Zapata JK, Azcona-Sanjulian MC, Catalán V, Ramírez B, Silva C, Rodríguez A, Escalada J, Frühbeck G, Gómez-Ambrosi J.
-
Talanta. 2023 Aug 30;267:125129. doi: 10.1016/j.talanta.2023.125129. Online ahead of print.
2023/09/05
WO(3) nanosheets with peroxidase-like activity and carbon dots based ratiometric fluorescent strategy for xanthine oxidase activity sensing and inhibitor screening
Jiang X, Liu W, Li Y, Zhu W, Liu H, Wen Y, Bai R, Luo X, Zhang G, Zhao Y.
-
Acta Pharm Sin B. 2023 Aug;13(8):3454-3470. doi: 10.1016/j.apsb.2023.02.011. Epub 2023 Feb 24.
2023/09/01
Rapidly separating dissolving microneedles with sustained-release colchicine and stabilized uricase for simplified long-term gout management
Yang Y, Li Z, Huang P, Lin J, Li J, Shi K, Lin J, Hu J, Zhao Z, Yu Y, Chen H, Zeng X, Mei L.
-
J Orthop Case Rep. 2023 Aug;13(8):89-92. doi: 10.13107/jocr.2023.v13.i08.3828.
2023/09/01
Atypical Presentation of Gouty Tophus as Posterior Cruciate Ligament Cyst: A Case Report
Satti LR, Mootha AK, Bajjangi US, Gundu G.
-
Pharmacoepidemiol Drug Saf. 2023 Aug 31. doi: 10.1002/pds.5684. Online ahead of print.
2023/09/01
Improving the accuracy of automated gout flare ascertainment using natural language processing of electronic health records and linked Medicare claims data
Yoshida K, Cai T, Bessette LG, Kim E, Lee SB, Zabotka LE, Sun A, Mastrorilli JM, Oduol TA, Liu J, Solomon DH, Kim SC, Desai RJ, Liao KP.
-
Ann Rheum Dis. 2023 Aug 31:ard-2023-224731. doi: 10.1136/ard-2023-224731. Online ahead of print.
2023/09/01
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial
Stamp L, Horne A, Mihov B, Drake J, Haslett J, Chapman PT, Frampton C, Dalbeth N.